Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis

Published:2018-11 Issue:5 Volume:154 Page:1061-1069
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Palmer Scott M.,Snyder Laurie,Todd Jamie L.,Soule Benjamin,Christian Rose,Anstrom Kevin,Luo Yi,Gagnon Robert,Rosen Glenn

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference12 articles.

1. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am J Respir Crit Care Med,2011

2. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials;Noble;Lancet,2011

3. Investigational approaches to therapies for idiopathic pulmonary fibrosis;Gomer;Expert Opin Investig Drugs,2010

4. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;N Engl J Med,2014

5. Pirfenidone reduces respiratory-related hospitalizations in idiopathic pulmonary fibrosis;Ley;Am J Respir Crit Care Med,2017

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis;Pharmaceutical Science Advances;2024-12

2. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

3. Highlights on Future Treatments of IPF: Clues and Pitfalls;International Journal of Molecular Sciences;2024-08-01

4. Spotlight on plasticity-related genes: Current insights in health and disease;Pharmacology & Therapeutics;2024-08

5. Hypoxia Promotes Invadosome Formation by Lung Fibroblasts;Cells;2024-07-06